|Congenital lamellar ichthyosis in Tunisia is caused by a founder nonsense mutation in the TGM1 gene.|
|Jump to Full Text|
|PMID: 23192619 Owner: NLM Status: Publisher|
|Lamellar ichthyosis (LI, MIM# 242300) is a severe autosomal recessive genodermatosis present at birth in the form of collodion membrane covering the neonate. Mutations in the TGM1 gene encoding transglutaminase-1 are a major cause of LI. In this study molecular analysis of two LI Tunisian patients revealed a common nonsense c.788G>A mutation in TGM1 gene. The identification of a cluster of LI pedigrees carrying the c.788G>A mutation in a specific area raises the question of the origin of this mutation from a common ancestor. We carried out a haplotype-based analysis by way of genotyping 4 microsatellite markers and 8 SNPs flanking and within the TGM1 gene spanning a region of 6 Mb. Haplotype reconstruction from genotypes of all members of the affected pedigrees indicated that all carriers for the mutation c.788G>A harbored the same haplotype, indicating common ancestor. The finding of a founder effect in a rare disease is essential for the genetic diagnosis and the genetic counselling of affected LI pedigrees in Tunisia.|
|Nacim Louhichi; Ikhlass Hadjsalem; Slaheddine Marrakchi; Fatma Trabelsi; Abderrahmen Masmoudi; Hamida Turki; Faiza Fakhfakh|
Related Documents :
|23898109 - Association of interleukin-10 (il10) promoter genotypes with nasopharyngeal carcinoma r...
23937619 - Can exploiting natural genetic variation in leaf photosynthesis contribute to increasin...
23286339 - Spherical nucleic acid enhanced fo-spr dna melting for detection of mutations in legion...
23738319 - Molecular analysis of twist1 and fgf receptors in a rabbit model of craniosynostosis: l...
22962479 - Reveal--visual eqtl analytics.
24302549 - A missense polymorphism in atf6 gene is associated with susceptibility to hepatocellula...
10827109 - The exon 13 duplication in the brca1 gene is a founder mutation present in geographical...
23227219 - Investigating the role of the melanocortin-1 receptor gene in an extreme case of microg...
17555409 - Tlr2 arg753gly, tlr4 asp299gly and thr399ile gene polymorphisms are not associated with...
|Type: JOURNAL ARTICLE Date: 2012-11-29|
|Title: Molecular biology reports Volume: - ISSN: 1573-4978 ISO Abbreviation: Mol. Biol. Rep. Publication Date: 2012 Nov|
|Created Date: 2012-11-29 Completed Date: - Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 0403234 Medline TA: Mol Biol Rep Country: -|
|Languages: ENG Pagination: - Citation Subset: -|
|Human Molecular Genetic Laboratory, Faculty of Medicine of Sfax, Avenue Magida Boulila, 3029, Sfax, Tunisia, email@example.com.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Mol Biol Rep
Journal ID (iso-abbrev): Mol. Biol. Rep
Publisher: Springer Netherlands, Dordrecht
© The Author(s) 2012
Received Day: 15 Month: 9 Year: 2012
Accepted Day: 20 Month: 11 Year: 2012
Electronic publication date: Day: 29 Month: 11 Year: 2012
pmc-release publication date: Day: 29 Month: 11 Year: 2012
Print publication date: Month: 3 Year: 2013
Volume: 40 Issue: 3
First Page: 2527 Last Page: 2532
PubMed Id: 23192619
Publisher Id: 2333
|Congenital lamellar ichthyosis in Tunisia is caused by a founder nonsense mutation in the TGM1 gene|
Address: +216-98-546-514 +216-74-461-403 firstname.lastname@example.org
Human Molecular Genetic Laboratory, Faculty of Medicine of Sfax, Avenue Magida Boulila, 3029 Sfax, Tunisia
Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
Autosomal recessive congenital ichthyosis (ARCI) is a rare, clinically and genetically heterogeneous group of cornification diseases. It defines three clinical subtypes which include the spectrum of lamellar ichthyosis (LI; OMIM 242300), congenital ichthyosiform erythroderma (CIE; OMIM 242100) and recently harlequin ichthyosis (HI; OMIM 242500) . The ARCI is characterized by epidermal scaling, often collodion membrane at birth, ectropion, eclabium, alopecia, palmar-plantar hyperkeratosis, hypohidrosis and/or variable erythema .
Over the last decade at least six different genes have been implicated in the etiology of ARCI, all of which encode proteins essential for the formation of the skin barrier: TGM1 [3, 4], ABCA12 [5, 6], two lipoxygenase genes (ALOXE3 and ALOX12B) [7, 8], ichthyin (NIPAL4)  and CYP4F2 homolog (FLJ39501) .
Lamellar ichthyosis (LI) constitutes a rare disease but its prevalence may increase in population which has a high consanguinity owing to fonder effect [11–13]. The most common cause of LI/CIE is inactivating mutations in the TGM1 gene, which encodes transglutaminase-1, an enzyme that crosslinks proteins in the cornified cell envelope [4, 14].
The TGM1 gene has 14,095 bp, including 2,454 bp of coding sequence, and spans 15 exons (GenBankNM_000359.2). It encodes for the transglutaminase-1 (TGase-1) enzyme, which has 817 amino acid residues and a molecular weight of ~89 kDa (GenBank NM_000359.2) [15, 16]. It is a catalytic membrane-bound enzyme involved in the formation of the epidermal cornified cell envelope, which acts as a mechanical barrier to protect against water loss and infectious agents . Up to now, more than 130 TGM1 different pathogenic mutations have been reported in the literature associated with LI/CIE phenotypic spectrum in patients from diverse ethnic backgrounds . TGM1 mutations include missense, nonsense, and splice site mutations. The majority are single-base changes; rarely, insertions or deletions are found.
This study presents detailed molecular analysis of lamellar ichthyosis in two Tunisian patients belonging to two consanguineous families. They present a common nonsense mutation c.788G>A in TGM1 gene. Since it is the only mutation described to be responsible for the LI in Tunisia, we confirmed a founder effect using polymorphic microsatellite markers.
Two patients belonging to two Tunisian families were born to healthy consanguineous parents. Genealogical investigation was performed and excluded any close relation between both families. Five additional healthy siblings and the parents were also recruited. Informed consent was obtained from patients and control individuals in accordance with the ethics committee of Hedi Chaker Hospital (Sfax, Tunisia). The diagnosis of LI was made on the basis of clinical manifestation; a detailed medical and dermatologic history was obtained from the affected persons. They were examined more than one time over the period of 10 years so that potential changes in phenotype could be evaluated. Blood samples were collected from family members and healthy individuals. Genomic DNA was extracted from the whole blood following a standard phenol–chloroform method .
The 15 exons and flanking intron region of the TGM1 gene were tested for mutation in the ARCI patients by sequence analysis. Following DNA extraction, the coding regions and intron–exon boundaries of the TGM1 gene were amplified by polymerase chain reaction (PCR) using generated primers covering the entire coding region (Table 1). PCR was carried out on 50 μl volume samples, in a GeneAmp® PCR system 9700 (Applied Biosystems, Foster City, CA, USA). Each sample contains 100 ng of genomic DNA, 0.4 μM of each primer, 0.2 mM of dNTPs, 1 IU of Amplitaq and 10× PCR Buffer II in a final concentration of 1 × 1.5 mM of MgCl2. The mixture was denatured during 10 min at 95 °C and then followed by 35 cycles: denaturing at 95 °C for 45 s, annealing at 65/60 °C for 45 s and an extension at 72 °C for 45 s; with a final extension at 72 °C for 7 min. Thereafter, the purified amplicons were directly sequenced using a dye terminator cycle sequencing kit V1.1 with an ABI sequence analyser 3100 avant (Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s recommendations.
For the haplotypic analyses, we screened four microsatellite markers D14S283, D14S275, D14S72 and D14S80. They occur in the 5′ and 3′ flanking region of the TGM1 gene and reported as highly polymorphic STR . Sequences of the primers for genetic markers were obtained from UNISTS (http://www.ncbi.nlm.nih.gov/unists).
Fluorescent dye-labeled microsatellite markers were genotyped for all the family members. We used the True Allele PCR Premix (Applied Biosystems, Foster City, CA) for PCR reactions according to the manufacturer’s instructions. Fluorescently-labelled alleles were analysed on an ABI PRISM 3100-Avant automated Genetic Analyser (Applied Biosystems, Foster City, CA). Genotypes were determined using the GenScan™ software (Applied Biosystems, Foster City, CA). The haplotype co-segregating with the disease was derived from the segregation of markers within the two pedigrees.
We identified two unrelated Tunisian families with two LI patients (MAS and NC). The healthy parents were consanguineous and originated from south Tunisia. Clinical data indicated that the initial presentation was a congenital onset of the disease with a history of collodion presentation and heat intolerance. MAS is a 14-year old son, second child of healthy parents who are first cousins, was born at term. Since his birth he developed a severe lamellar ichthyosis. He had one brother died for unknown reasons. NC is a 21-year old girl was referred to the dermatology department at Hedi Chaker Hospital in Sfax for a severe lamellar ichthyosis since birth, she is the first child of healthy consanguineous parents.
The two patients (MAS and NC) showed a normal intellect. No evidence of congenital hypothyroidism or sensitivity to gluten usually associated to LI Tunisian phenotype was noted. The main clinical features of the two patients are summarized in Table 2 (Table 2; Fig. 1).
Mutation screening of the TGM1 coding region and intron–exon boundaries revealed the c.788G>A nonsense mutation (g.3139 G>A) in the two patients at homozygous state associated with a severe LI phenotype (Fig. 2). It occurs in exon 5 and results in the substitution of tryptophan (TGG) by a stop codon (TGA) at amino acid position 263 (p.W263X). Verification of transmission of this mutation was done for all families members. This variant was absent even in the heterozygous state by direct sequencing in 100 Tunisian control chromosomes.
According to the prevalence of the c.788G>A mutation among our group of patients and since the studied families sharing the same mutation c.788G>A are all originated from south Tunisia, we test the hypothesis that this mutation arose on a founder ancestor in the distant past. For these reason, we analyzed four polymorphic genetic markers and explored 8 SNPs encompassing approximately 6 Mb in and around the TGM1 gene to construct haplotypes for the mutant and normal TGM1 chromosomes in the families. Patient’s haplotypes showed that the c.788G>A mutation has been transmitted in conserved bloc of 2 Mb. A conserved haplotype encompassing the markers D14S275–D14S283 was found (Fig. 3). This result revealed that the c.788G>A mutation is not the result of separate mutation occurring independently in different individuals, but is the result of a one-time mutation occurring in a common ancestor of all autosomal recessive congenital lamellar ichthyosis families in Tunisia.
In the present study, we report two Tunisian LI patients associated with nonsense c.788G>A mutation in the TGM1 gene predicting an amino acid substitution of tryptophan for a stop codon (p.W263X). It introduces a premature stop codon after nearly one-third of the TGase-1 polypeptide and leads to a truncated enzyme lacking the majority of the active site. To the best of our knowledge, this homozygous mutation is not prevalent worldwide, being found in only two Tunisian LI patients [14, 18, 19] and suggested to be a recurrent mutation in Tunisian patients affected by severe LI.
The clinical phenotypes observed in our patients correspond to those that have been described as lamellar ichthyosis in the literature . It is noteworthy that the previous Tunisian patients described by Esposito et al. and Hennies et al. [18, 19], additionally suffered from congenital hypothyroidism or from severe gluten sensitive enteropathy respectively. Moreover, Oji et al.  report a relatively mildly affected girl from France with compound heterozygous genotype c.788G>A/c.919C>G and abnormal in vivo TGase-1 activity in affected skin areas.
Several reports suggest a link between thyroid diseases and ichthyosis. Firstly, in patients affected by both autoimmune thyroid disease and acquired ichthyosis, thyroid hormone replacement resulted in improvement of ichthyosis [20, 22]. Moreover, TGase-1 deficient LI was also found to be associated to congenital hypothyroidism in a child of consanguineous parents . In such case, ichthyosis and hypothyroidism could be co-inherited, since the TGM1 and TSHR genes maps to the same chromosome localization (14q). This inter-familial variability, in clinical phenotype, encountered in LI patients sharing the same mutation could be due to differences in environmental factors or to the genetic background (influence of modifier gene) or both .
With regard to the nonsense nature of the c.788G>A mutation, two hypotheses may be evoked: either the translation of a truncated transglutaminase I protein lacking catalytic domain (core domain), or possibly the degradation of the nonsense mRNA that manifests as a complete absence of transglutaminase I protein. The most probable hypothesis is that the resulting nonsense mRNA is probably destroyed by the quality control surveillance mechanism NMD (nonsense-mediated mRNA decay) according to the PTC position rule (>50–55 nt upstream of the last exon–exon junction), which is detected in our patient at position c.788 .
Previously, using 32P labelled TGM1 probes, mRNA was shown to be absent from cultured keratinocytes taken from a patient homozygous for the nonsense mutation R127X . Northern blotting of tissue taken from a skin biopsy and cultured keratinocytes from a patient homozygous for the truncating mutation c.1297delT showed absent TGase-1 mRNA in vitro . NMD, which decreases the amount of cellular mRNA with premature termination codons (PTCs), could be the mechanism that explains these observations .
High carrier rates are usually attributed to a founder effect in endogamic and consanguineous populations . They are usually evidenced by conservation of haplotypes with directly associated markers. Since the c.788G>A mutation has not been described elsewhere, it seems to be specific to the Tunisian population. According to such finding and in agreement with the prevalence of this mutation reported in our study and the previous ones [18, 19], we demonstrated that a clustering of g.3139 G>A mutation in two Tunisian families is due to a common founder ancestor. In fact, the analysis of 4 microsatellite markers and 8 SNPs flanking or within the TGM1 gene revealed a common haplotype carried by the patients sharing the same g.3139 G>A mutation. Hence, we suggest that this founder haplotype which ranges over 2 Mb could be the same for the two patients already reported and sharing the same mutation. In addition, the two families carrying the g.3139 G>A mutation are originated from southern Tunisia. Such rural communities are characterized by a high consanguinity and endogamy rates which supports our findings. Evidence for a founder effect of TGM1 gene has been also reported in American and Spanish populations [2, 29]. Given that it was the only founder mutation described so far in Tunisia, the c.788G>A mutation could be the only variation responsible for LI in Tunisian population.
In summary, the conservation of a single haplotype surrounding the c.788G>A mutation suggested that this ancestor haplotype has a single origin. The finding of a founder effect in a unique recurrent mutation in a rare disease is essential for the implementation of protocols for genetic diagnosis, for genetic counselling of affected pedigrees and is fundamental to search for new therapies.
The authors are indebted to the patients and their families who participated in this study for their constant support and motivation. This work was supported by the Tunisian Ministry of Higher Education and Scientific Research.
None of the authors has any conflict of interest.
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
|1..||Oji V, Tadini G, Akiyama M, Blanchet Bardon C, Bodemer C, Bourrat E, Coudiere P, DiGiovanna JJ, Elias P, Fischer J, Fleckman P, Gina M, Harper J, Hashimoto T, Hausser I, Hennies HC, Hohl D, Hovnanian A, Ishida-Yamamoto A, Jacyk WK, Leachman S, Leigh I, Mazereeuw-Hautier J, Milstone L, Morice-Picard F, Paller AS, Richard G, Schmuth M, Shimizu H, Sprecher E, Van Steensel M, Taïeb A, Toro JR, Vabres P, Vahlquist A, Williams M, Traupe H (2010) Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol 63(4):607–641|
|2..||Herman ML,Farasat S,Steinbach PJ,Wei MH,Toure O,Fleckman P,Blake P,Bale SJ,Toro JR. Transglutaminase-1 gene mutations in autosomal recessive congenital ichthyosis: summary of mutations (including 23 novel) and modeling of TGase-1Hum MutatYear: 200930453754710.1002/humu.2095219241467|
|3..||Huber M,Rettler I,Bernasconi K,Frenk E,Lavrijsen SP,Ponec M,Bon A,Lautenschlager S,Schorderet DF,Hohl D. Mutations of keratinocyte transglutaminase in lamellar ichthyosisScienceYear: 1995267519752552810.1126/science.78249527824952|
|4..||Russell LJ,DiGiovanna JJ,Rogers GR,Steinert PM,Hashem N,Compton JG,Bale SJ. Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosisNat GenetYear: 19959327928310.1038/ng0395-2797773290|
|5..||Akiyama M,Sugiyama-Nakagiri Y,Sakai K,McMillan JR,Goto M,Arita K,Tsuji-Abe Y,Tabata N,Matsuoka K,Sasaki R,Sawamura D,Shimizu H. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transferJ Clin InvestYear: 200511571777178410.1172/JCI2483416007253|
|6..||Kelsell DP,Norgett EE,Unsworth H,Teh MT,Cullup T,Mein CA,Dopping-Hepenstal PJ,Dale BA,Tadini G,Fleckman P,Stephens KG,Sybert VP,Mallory SB,North BV,Witt DR,Sprecher E,Taylor AE,Ilchyshyn A,Kennedy CT,Goodyear H,Moss C,Paige D,Harper JI,Young BD,Leigh IM,Eady RA,O’Toole EA. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosisAm J Hum GenetYear: 200576579480310.1086/42984415756637|
|7..||Jobard F,Lefèvre C,Karaduman A,Blanchet-Bardon C,Emre S,Weissenbach J,Ozgüc M,Lathrop M,Prud’homme JF,Fischer J. Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1Hum Mol GenetYear: 200211110711310.1093/hmg/11.1.10711773004|
|8..||Eckl KM,Krieg P,Küster W,Traupe H,André F,Wittstruck N,Fürstenberger G,Hennies HC. Mutation spectrum and functional analysis of epidermis-type lipoxygenases in patients with autosomal recessive congenital ichthyosisHum MutatYear: 200526435136110.1002/humu.2023616116617|
|9..||Lefèvre C,Bouadjar B,Karaduman A,Jobard F,Saker S,Ozguc M,Lathrop M,Prud’homme JF,Fischer J. Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosisHum Mol GenetYear: 200413202473248210.1093/hmg/ddh26315317751|
|10..||Lefèvre C,Bouadjar B,Ferrand V,Tadini G,Mégarbané A,Lathrop M,Prud’homme JF,Fischer J. Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3Hum Mol GenetYear: 200615576777610.1093/hmg/ddi49116436457|
|11..||Fachal L,Rodríguez-Pazos L,Ginarte M,Toribio J,Salas A,Vega A. Multiple local and recent founder effects of TGM1 in Spanish familiesPLoS OneYear: 201274e3358010.1371/journal.pone.003358022511925|
|12..||Rodríguez-Pazos L,Ginarte M,Fachal L,Toribio J,Carracedo A,Vega A. Analysis of TGM1, ALOX12B, ALOXE3, NIPAL4 and CYP4F22 in autosomal recessive congenital ichthyosis from Galicia (NW Spain): evidence of founder effectsBr J DermatolYear: 2011165490691110.1111/j.1365-2133.2011.10454.x21668430|
|13..||Pigg M,Gedde-Dahl T Jr,Cox D,Hausser I,Anton-Lamprecht I,Dahl N. Strong founder effect for a transglutaminase 1 gene mutation in lamellar ichthyosis and congenital ichthyosiform erythroderma from NorwayEur J Hum GenetYear: 19986658959610.1038/sj.ejhg.52002249887377|
|14..||Farasat S,Wei MH,Herman M,Liewehr DJ,Steinberg SM,Bale SJ,Fleckman P,Toro JR. Novel transglutaminase-1 mutations and genotype-phenotype investigations of 104 patients with autosomal recessive congenital ichthyosis in the USAJ Med GenetYear: 200946210311110.1136/jmg.2008.06090518948357|
|15..||Kim HC,Idler WW,Kim IG,Han JH,Chung SI,Steinert PM. The complete amino acid sequence of the human transglutaminase K enzyme deduced from the nucleic acid sequences of cDNA clonesJ Biol ChemYear: 199126615365391670769|
|16..||Kim IG,McBride OW,Wang M,Kim SY,Idler WW,Steinert PM. Structure and organization of the human transglutaminase 1 geneJ Biol ChemYear: 199226711771077171348508|
|17..||Kawasaki E,Erlich H. Polymerase chain reaction and analysis of cancer cell markersJ Natl Cancer InstYear: 1990821080680710.1093/jnci/82.10.8062332893|
|18..||Hennies HC,Raghunath M,Wiebe V,Vogel M,Velten F,Traupe H,Reis A. Genetic and immunohistochemical detection of mutations inactivating the keratinocyte transglutaminase in patients with lamellar ichthyosisHum GenetYear: 1998102331431810.1007/s0043900506979544844|
|19..||Esposito G,De Falco F,Brazzelli V,Montanari L,Larizza D,Salvatore F. Autosomal recessive congenital ichthyosis and congenital hypothyroidism in a Tunisian patient with a nonsense mutation in TGM1J Dermatol SciYear: 200955212813010.1016/j.jdermsci.2009.05.00219556108|
|20..||Kurtoğlu S,Caksen H,Erdoğan R,Kisaarslan AF. Collodion baby concomitant with congenital hypothyroidism: a patient report and review of the literatureJ Pediatr Endocrinol MetabYear: 19981145695739777579|
|21..||Oji V,Hautier JM,Ahvazi B,Hausser I,Aufenvenne K,Walker T,Seller N,Steijlen PM,Küster W,Hovnanian A,Hennies HC,Traupe H. Bathing suit ichthyosis is caused by transglutaminase-1 deficiency: evidence for a temperature-sensitive phenotypeHum Mol GenetYear: 200615213083309710.1093/hmg/ddl24916968736|
|22..||Brazzelli V,Prestinari F,Barbagallo T,Bellani E,Calcaterra V,Larizza D,Lauriola MM,Borroni G. Acquired ichthyosis and hypertrichosis due to autoimmune thyroiditis: therapeutic response to thyroxine replacementPediatr DermatolYear: 200522544744910.1111/j.1525-1470.2005.00114.x16190999|
|23..||Small K,Ginsburg H,Greco MA,Sarita-Reyes C,Kupchik G,Blei F. More than skin deep: a case of congenital lamellar ichthyosis, lymphatic malformation, and other abnormalitiesLymphat Res BiolYear: 200861394410.1089/lrb.2007.102018361769|
|24..||Génin E,Feingold J,Clerget-Darpoux F. Identifying modifier genes of monogenic disease: strategies and difficultiesHum GenetYear: 2008124435736810.1007/s00439-008-0560-218784943|
|25..||Maquat LE. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamicsNat Rev Mol Cell BiolYear: 200452899910.1038/nrm131015040442|
|26..||Huber M,Yee VC,Burri N,Vikerfors E,Lavrijsen AP,Paller AS,Hohl D. Consequences of seven novel mutations on the expression and structure of keratinocyte transglutaminaseJ Biol ChemYear: 199727234210182102610.1074/jbc.272.34.210189261103|
|27..||Huber M,Rettler I,Bernasconi K,Wyss M,Hohl D. Lamellar ichthyosis is genetically heterogeneous–cases with normal keratinocyte transglutaminaseJ Invest DermatolYear: 1995105565365410.1111/1523-1747.ep123241227594637|
|28..||Louhichi N,Medhaffar M,Hadjsalem I,Mkaouar-Rebai E,Fendri-Kriaa N,Kanoun H,Yaïch F,Souissi T,Elloumi M,Fakhfakh F. Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effectAnn HematolYear: 201089549950410.1007/s00277-009-0863-y19937244|
|29..||Shevchenko YO,Compton JG,Toro JR,DiGiovanna JJ,Bale SJ. Splice-site mutation in TGM1 in congenital recessive ichthyosis in American families: molecular, genetic, genealogic, and clinical studiesHum GenetYear: 2000106549249910.1007/s00439000028410914678|
Primer pairs of TGM 1 gene used for detection of mutation by DNA sequencing
|Exon||Forward||Reverse||PCR size (bp)|
Clinical data of LI patients
|Patient 1 (MAS)||Patient 2 (NC)|
|Collodion baby||Collodion baby|
|Erythematous skin with large thick scaly||Episodes of bullous detachment in childhood|
|Brownish scales of the limbs||Erythematous skin|
|Everted lips||Brownish scales of the limbs|
|Adhered ears||No everted lips|
|Ectropion eyelid, broad nasal base||Adhered ears|
|Palmoplantar keratoderma||Ectropion eyelid|
|Brachydactyly and tapering fingernails||Palmoplantar keratoderma|
|Frontal hairline rarefaction||Brachydactyly (Fig. 1) and tapering fingernails|
Keywords: Keywords TGM1 gene, Nonsense mutation, Founder effect, c.788G>A, p.W263X, Congenital lamellar ichthyosis.
Previous Document: Association between subcutaneous and intramuscular fat content in porcine ham and loin depending on ...
Next Document: Risk of lymph node metastases from intramucosal gastric cancer in relation to histological types: ho...